Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...

Journal of Nuclear Medicine October 2024, jnumed.124.268278; DOI: https://doi.org/10.2967/jnumed.124.268278 ...

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands ...

Learning Objectives 1. Review techniques for RBC preparation and labelling. 2. Review imaging protocol and imaging findings. 3. Present examples where SPECT/CT helped with hemangioma ...

Journal of Nuclear Medicine October 2024, jnumed.124.267948; DOI: https://doi.org/10.2967/jnumed.124.267948 ...

Journal of Nuclear Medicine October 2024, jnumed.124.268033; DOI: https://doi.org/10.2967/jnumed.124.268033 ...

Journal of Nuclear Medicine September 2024, jnumed.124.267489; DOI: https://doi.org/10.2967/jnumed.124.267489 ...

Objectives To measure the urinary excretion of Yttrium-90 (90Y) following intra-arterial (IA) treatment with 90Y-microspheres for liver tumours. Methods Urine was collected over 12h. 3 samples of 2 ml ...

Journal of Nuclear Medicine September 2024, jnumed.124.268151; DOI: https://doi.org/10.2967/jnumed.124.268151 ...

Journal of Nuclear Medicine September 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145 ...

Journal of Nuclear Medicine October 2024, jnumed.124.267529; DOI: https://doi.org/10.2967/jnumed.124.267529 ...

Journal of Nuclear Medicine October 2024, jnumed.124.268351; DOI: https://doi.org/10.2967/jnumed.124.268351 ...